Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa

Author： Shoji Mamoru   Sun Aiming   Kisiel Walter   Lu Yang   Shim Hyunsuk   McCarey Bernard   Nichols Christopher   Parker Ernest   Pohl Jan   Mosley Cara   Alizadeh Aaron   Liotta Dennis   Snyder James  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.16, Iss.3, 2008-04, pp. : 185-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Tissue Factor•Factor VIIa for Anticoagulant Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 17, 2004-09 ,pp. : 2275-2290

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Discovery of Tissue Factor/Factor VIIa Inhibitors and Dual Inhibitors of Factor VIIa/Factor Xa

By  

Current Pharmaceutical Design, Vol. 11, Iss. 32, 2005-12 ,pp. : 4207-4227

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant Factor VIIA, its Clinical Properties, and the Tissue Factor Pathway of Coagulation

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1111-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way

By Brousseau Catherine   Morissette Guillaume   Fortin Jean-Philippe   Marceau François   Petitclerc Eric  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 9, 2009-09 ,pp. : 694-701

NRC Research Press

Access to resources Recommend Favorite

Peptides Targeting Angiogenesis Related Growth Factor Receptors

By  

Current Pharmaceutical Design, Vol. 15, Iss. 21, 2009-07 ,pp. : 2414-2429

Bentham Science Publishers

Access to resources Recommend Favorite